Giri S N, Hyde D M, Schwartz L W, Younker W R
Am J Pathol. 1982 Oct;109(1):115-22.
The development of bleomycin-induced lung fibrosis was studied in hamsters drinking tap water or 2% alpha-difluoromethylornithine (DFMO) dissolved in tap water for 14 days. The fibrotic lesions in the lung were evaluated by biochemical measurements of total neutral salt soluble (NSS) and insoluble (NSI) collagens and by morphometric histopathologic techniques. Daily ingestion of DFMO failed to offer any protection against bleomycin-induced lung fibrosis; instead, it increased the deposition of total lung NSI collagen to 396% of control, as compared with 145% of control caused by bleomycin treatment alone. Daily intake of DFMO by itself increased the accumulation of total lung NSI collagen to 250% of control, as opposed to a 145% increase caused by bleomycin treatment alone. Histopathologically, the lung lesions in hamsters treated with bleomycin and DFMO were qualitatively similar to those of hamsters treated with bleomycin alone. However, morphometric estimates revealed that of lung lesions were more diffuse and severe in the former than in the latter group.
在饮用自来水或溶解有2%α-二氟甲基鸟氨酸(DFMO)的自来水14天的仓鼠中,研究了博来霉素诱导的肺纤维化的发展情况。通过对总中性盐可溶性(NSS)和不溶性(NSI)胶原蛋白进行生化测量,并采用形态计量组织病理学技术,对肺部的纤维化病变进行评估。每日摄入DFMO未能对博来霉素诱导的肺纤维化提供任何保护作用;相反,与仅用博来霉素治疗导致对照组的145%相比,它使肺总NSI胶原蛋白的沉积增加至对照组的396%。DFMO自身每日摄入量使肺总NSI胶原蛋白的积累增加至对照组的250%,而仅用博来霉素治疗导致增加145%。在组织病理学上,用博来霉素和DFMO治疗的仓鼠的肺部病变在性质上与仅用博来霉素治疗的仓鼠相似。然而,形态计量估计显示,前者的肺部病变比后者更弥漫、更严重。